Muge Nur Engin

Somatostatin receptor-positive breast lesions on 68Ga-DOTATATE PET/CT

Y. Şanlı, A. Mudun, S. Kuyumcu, 2021, Annals of Nuclear Medicine.

Title: Clinical impact of lower limb imaging in 68 Ga-PSMA PET-CT for patients with prostate cancer

E. Demirci, Y. Şanlı, S. Kuyumcu, 2019 .

Y90 selective internal radiation therapy and peptide receptor radionuclide therapy for the treatment of metastatic neuroendocrine tumors: combination or not?

C. Türkmen, Z. Özkan, A. Poyanli, 2020, Nuclear medicine communications.

Does bone scintigraphy still have a role in the era of 68 Ga-PSMA PET/CT in prostate cancer?

Y. Şanlı, S. Kuyumcu, Z. G. Ozkan, 2020, Annals of Nuclear Medicine.

Detection of metastases in newly diagnosed prostate cancer by using 68Ga-PSMA PET/CT and its relationship with modified D’Amico risk classification

O. Sanli, Y. Şanlı, S. Erdem, 2020, European Journal of Nuclear Medicine and Molecular Imaging.

Clinical Impact of Lower-Limb Imaging in 68Ga-PSMA PET/CT for Patients with Prostate Cancer

E. Demirci, Y. Şanlı, S. Kuyumcu, 2019, The Journal of Nuclear Medicine Technology.